EKF Diagnostics (LON:EKF) Share Price Crosses Below Two Hundred Day Moving Average – Time to Sell?

EKF Diagnostics Holdings plc (LON:EKF)’s stock price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 25.91 ($0.33) and traded as low as GBX 20.10 ($0.26). EKF Diagnostics shares last traded at GBX 20.76 ($0.27), with a volume of 863,267 shares trading hands.

EKF Diagnostics Stock Down 1.5 %

The company has a market capitalization of £101.78 million, a PE ratio of 21.31 and a beta of 0.57. The company’s fifty day moving average is GBX 23.23 and its 200-day moving average is GBX 25.85. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.77 and a current ratio of 4.60.

EKF Diagnostics (LON:EKF) last announced its quarterly earnings data on Tuesday, March 25th. The company reported GBX 1.38 ($0.02) EPS for the quarter. EKF Diagnostics had a net margin of 9.37% and a return on equity of 7.03%. As a group, analysts predict that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current fiscal year.

Insider Buying and Selling at EKF Diagnostics

In related news, insider Gavin T. Jones acquired 50,000 shares of the company’s stock in a transaction on Tuesday, March 25th. The stock was acquired at an average price of GBX 22 ($0.28) per share, with a total value of £11,000 ($14,162.48). Insiders own 5.24% of the company’s stock.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

? Point-of-Care analysers in the key areas of Hematology and Diabetes

? Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.